October 14, 2021 — There will be 9 late-breaking trials and 13 late-breaking science presentations at the 2021 Transcatheter Cardiovascular Therapeutics (TCT) meeting, sponsored by the Cardiovascular ...
-
-
October 7, 2021 – The U.S. Food and Drug Administration (FDA) recently granted the breakthrough therapy designation for empagliflozin (Jardiance) as an investigational treatment for adults with heart ...
-
October 6, 2021 — Data presented during the late-breaking science session at the European Society of Cardiology (ESC) 2021 Congress showed the integration of perivascular fat attenuation in coronary ...
-
October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021 European Society of Cardiology (ESC) Congress. Drones Could Deliver ...
October 20, 2021 — Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions ...
October 20, 2021
October 20, 2021 — 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a late-breaking ...
October 20, 2021
October 20, 2021 — Boston Scientific Corporation announced positive data for the Eluvia Drug-Eluting Vascular Stent ...
October 20, 2021
October 14, 2021 — There will be 9 late-breaking trials and 13 late-breaking science presentations at the 2021 ...
October 14, 2021
October 7, 2021 – The U.S. Food and Drug Administration (FDA) recently granted the breakthrough therapy designation for ...
October 07, 2021
October 6, 2021 — Data presented during the late-breaking science session at the European Society of Cardiology (ESC) 20 ...
October 06, 2021
October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021 ...
October 04, 2021
October 1, 2021 — A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in ...
October 04, 2021
October 1, 2021 — The European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization ...
October 04, 2021
Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...
October 04, 2021
MASTER DAPT Shows 1-month Dual Antiplatelet Therapy After Stent Benefits High Bleeding Risk Patients
October 4, 2021 — One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk ...
October 04, 2021
September 28, 2021 — Hemodynamic guided management using the CardioMEMS device may reduce heart failure hospitalizations ...
September 28, 2021
September 28, 2021 — Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ...
September 28, 2021![Test selection should be a shared decision between patient and physician rather than directed by insurers’ test substitution policies, according to a statement published online in the Journal of the American College of Cardiology.[1] The statement summarizes the proceedings of a recent summit convened by the American Society of Nuclear Cardiology (ASNC), leadership of the American College of Cardiology Imaging Council, American Society of Echocardiography (ASE), Society of Cardiovascular Computed Tomography](/sites/default/files/styles/content_feed_medium/public/Cardiac_imaging_Nuclear_echo_CT_MRI.jpg?itok=XH9oijOU)
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by ...
September 22, 2021
September 21, 2021 — The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and ...
September 21, 2021© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now